A CRITIQUE OF THE LAW AND PRACTICE ON PROTECTION OF CONSUMER'S OF PHARMACEUTICAL PRODUCTS IN UGANDA

TABLE OF CONTENTS

DECLARATION ........... ........................................................... .................... .. .............................. ... i

APPROVAL ........................................................................................ .................................. ......... ii

DEDICATION ............... ......................................................................... ....................................... iii

ACKNOWLEDGEMENT ........................ ..................................................................................... iv

GENERAL INTRODUCTION ....................................................................................................... I

1.1 Background ofthe study ................................... ............. ....................................................... I

1.2 Staternent of the Problem ........................ ...................................... ........................................ 3

1.3 Objectives of the study .......... ................................................................................................ 4

1.3.1 General Obj ective .............................................................. .. .................... ........................... 4

1. 3.3 Specific Objective .............................................................................................................. 4

1.4 Research Questions ........................................................................................................... .... 4

1.5 Scope ofthe study ........................................................... ....................... ............................... 5

1.5.1 Geographical Scope ...................................................... .......................................... ............ 5

1.5.2 Content Scope .................................................................................................................... 5

1.5.3 Tirne Scope ................................................................. ................... ..................................... 5

I .6 Significance of the study ....................................................................................................... 5

1.7 Li terature Rev i e~' ........... ....................................................................................................... 5

1.7.3 Challenges to consumer protection .................................................................................. I I

1.8 Methodology ....................................................................................................................... 12

I. 9 Organization Layout. ........................................................................................................... 12

CHAPTER TWO ............................................................................................... ........................... 13

I TERNATIONAL. CONTINENTAL, REGIONAL PROVISIONS ON CONSUMER

PROTECTION OF PHARMACEUTICAL PRODUCTS .............................. .................. ............ 13

2.0 Introduction ......... .. ........................................................ .... .................................................. 13

2. 1 International in strum ents ..................................................................................................... 13

2.2 Continental conventions on protection of consumers of pharmaceutical products ............. 16

2.3 East Ati" ican community on protection of consumers or pharmaceutical products ............ I 9

2.4 The east African community competition act, 2006 ........................................................... 19

CTIAPTER THREE .................... ............ ... .. ................. .............. ....... .... ................ .. .............. .. ..... 21

LEGAL AND INSTITUTIONAL FRAMEWORK ON CONSUMER ....................................... 21

v

PROTECTION OF PHARMACEUTICAL PRODUCTS IN UGANDA .................................... 21

3.0 Introduction ............. ................... ..................................................................... .................... 21

3 .I Legal framework on consumer protection of pharmaceutical products .............................. 21

3.2 Institutional fra1nework ......................................... .............................................................. 23

CHAPTER FOUR ......................................................................................................................... 28

PRESENTATION AND INTERPRETTION OF INFORMATION ............. ............................... 28

4.0 Introduction ....... ............................................................ ...................................................... 28

4. 1 Legal provisions on consumer protection of pharmaceutical products in Uganda ............. 28

4.2 Effect of contributions of the Food and Drugs Act and National drug policy and Act on

consumer protection of pharmaceutical products ......... .................. ........................................... 3 I

4.3 Legal challenges to consumer institutional framework on protection of pharmaceutical

products in Uganda .. .... ................................... .......... ................................................................. 33

4.4 Recommendations on how the challenges of consumer protection can be dealt with ........ 36

Cl-IAPTER FIVE .......................................................................................................................... 40

SUMMARY, CONCLUSION AND RECOMMENDATIONS ................................... ................ 40

5.0 I ntrodu